Frontiers in Nuclear Medicine最新文献

筛选
英文 中文
Comparative effectiveness of standard vs. AI-assisted PET/CT reading workflow for pre-treatment lymphoma staging: a multi-institutional reader study evaluation 治疗前淋巴瘤分期的标准 PET/CT 阅读工作流程与 AI 辅助阅读工作流程的效果比较:多机构阅读研究评估
Frontiers in Nuclear Medicine Pub Date : 2024-01-11 DOI: 10.3389/fnume.2023.1327186
R. Frood, Julien M. Y. Willaime, Brad Miles, Greg Chambers, H’ssein Al-Chalabi, Tamir Ali, Natasha Hougham, Naomi Brooks, George Petrides, Matthew Naylor, Daniel Ward, Tom Sulkin, Richard Chaytor, Peter Strouhal, Chirag Patel, A. F. Scarsbrook
{"title":"Comparative effectiveness of standard vs. AI-assisted PET/CT reading workflow for pre-treatment lymphoma staging: a multi-institutional reader study evaluation","authors":"R. Frood, Julien M. Y. Willaime, Brad Miles, Greg Chambers, H’ssein Al-Chalabi, Tamir Ali, Natasha Hougham, Naomi Brooks, George Petrides, Matthew Naylor, Daniel Ward, Tom Sulkin, Richard Chaytor, Peter Strouhal, Chirag Patel, A. F. Scarsbrook","doi":"10.3389/fnume.2023.1327186","DOIUrl":"https://doi.org/10.3389/fnume.2023.1327186","url":null,"abstract":"Fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) is widely used for staging high-grade lymphoma, with the time to evaluate such studies varying depending on the complexity of the case. Integrating artificial intelligence (AI) within the reporting workflow has the potential to improve quality and efficiency. The aims of the present study were to evaluate the influence of an integrated research prototype segmentation tool implemented within diagnostic PET/CT reading software on the speed and quality of reporting with variable levels of experience, and to assess the effect of the AI-assisted workflow on reader confidence and whether this tool influenced reporting behaviour.Nine blinded reporters (three trainees, three junior consultants and three senior consultants) from three UK centres participated in a two-part reader study. A total of 15 lymphoma staging PET/CT scans were evaluated twice: first, using a standard PET/CT reporting workflow; then, after a 6-week gap, with AI assistance incorporating pre-segmentation of disease sites within the reading software. An even split of PET/CT segmentations with gold standard (GS), false-positive (FP) over-contour or false-negative (FN) under-contour were provided. The read duration was calculated using file logs, while the report quality was independently assessed by two radiologists with >15 years of experience. Confidence in AI assistance and identification of disease was assessed via online questionnaires for each case.There was a significant decrease in time between non-AI and AI-assisted reads (median 15.0 vs. 13.3 min, p < 0.001). Sub-analysis confirmed this was true for both junior (14.5 vs. 12.7 min, p = 0.03) and senior consultants (15.1 vs. 12.2 min, p = 0.03) but not for trainees (18.1 vs. 18.0 min, p = 0.2). There was no significant difference between report quality between reads. AI assistance provided a significant increase in confidence of disease identification (p < 0.001). This held true when splitting the data into FN, GS and FP. In 19/88 cases, participants did not identify either FP (31.8%) or FN (11.4%) segmentations. This was significantly greater for trainees (13/30, 43.3%) than for junior (3/28, 10.7%, p = 0.05) and senior consultants (3/30, 10.0%, p = 0.05).The study findings indicate that an AI-assisted workflow achieves comparable performance to humans, demonstrating a marginal enhancement in reporting speed. Less experienced readers were more influenced by segmentation errors. An AI-assisted PET/CT reading workflow has the potential to increase reporting efficiency without adversely affecting quality, which could reduce costs and report turnaround times. These preliminary findings need to be confirmed in larger studies.","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":" 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139627094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Molecular imaging of cardiovascular diseases: current and emerging approaches in nuclear medicine 社论:心血管疾病的分子成像:核医学中当前和新兴的方法
Frontiers in Nuclear Medicine Pub Date : 2024-01-11 DOI: 10.3389/fnume.2023.1362018
Jonathan Vigne, Giorgio Treglia
{"title":"Editorial: Molecular imaging of cardiovascular diseases: current and emerging approaches in nuclear medicine","authors":"Jonathan Vigne, Giorgio Treglia","doi":"10.3389/fnume.2023.1362018","DOIUrl":"https://doi.org/10.3389/fnume.2023.1362018","url":null,"abstract":"","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"53 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139533930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The application of radionuclide therapy for breast cancer 应用放射性核素治疗乳腺癌
Frontiers in Nuclear Medicine Pub Date : 2024-01-10 DOI: 10.3389/fnume.2023.1323514
Anna Musket, Sandra Davern, Brianna M. Elam, Philip R. Musich, Jonathan P. Moorman, Yong Jiang
{"title":"The application of radionuclide therapy for breast cancer","authors":"Anna Musket, Sandra Davern, Brianna M. Elam, Philip R. Musich, Jonathan P. Moorman, Yong Jiang","doi":"10.3389/fnume.2023.1323514","DOIUrl":"https://doi.org/10.3389/fnume.2023.1323514","url":null,"abstract":"Radionuclide-mediated diagnosis and therapy have emerged as effective and low-risk approaches to treating breast cancer. Compared to traditional anatomic imaging techniques, diagnostic radionuclide-based molecular imaging systems exhibit much greater sensitivity and ability to precisely illustrate the biodistribution and metabolic processes from a functional perspective in breast cancer; this transitions diagnosis from an invasive visualization to a noninvasive visualization, potentially ensuring earlier diagnosis and on-time treatment. Radionuclide therapy is a newly developed modality for the treatment of breast cancer in which radionuclides are delivered to tumors and/or tumor-associated targets either directly or using delivery vehicles. Radionuclide therapy has been proven to be eminently effective and to exhibit low toxicity in eliminating both primary tumors and metastases, and even undetected tumors. In addition, the specific interaction between the surface modules of the delivery vehicles and the targets on the surface of tumor cells enables radionuclide targeting therapy, and this represents an exceptional potential for this treatment in breast cancer. This article reviews the development of radionuclide molecular imaging techniques that are currently employed for early breast cancer diagnosis and both the progress and challenges of radionuclide therapy employed in breast cancer treatment.","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"7 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139439474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automatic deep learning method for third lumbar selection and body composition evaluation on CT scans of cancer patients 针对癌症患者 CT 扫描的第三腰椎选择和身体成分评估的自动深度学习方法
Frontiers in Nuclear Medicine Pub Date : 2024-01-10 DOI: 10.3389/fnume.2023.1292676
Lidia Delrieu, Damien Blanc, A. Bouhamama, Fabien Reyal, Frank Pilleul, Victor Racine, A. Hamy, Hugo Crochet, Timothée Marchal, Pierre Etienne Heudel
{"title":"Automatic deep learning method for third lumbar selection and body composition evaluation on CT scans of cancer patients","authors":"Lidia Delrieu, Damien Blanc, A. Bouhamama, Fabien Reyal, Frank Pilleul, Victor Racine, A. Hamy, Hugo Crochet, Timothée Marchal, Pierre Etienne Heudel","doi":"10.3389/fnume.2023.1292676","DOIUrl":"https://doi.org/10.3389/fnume.2023.1292676","url":null,"abstract":"The importance of body composition and sarcopenia is well-recognized in cancer patient outcomes and treatment tolerance, yet routine evaluations are rare due to their time-intensive nature. While CT scans provide accurate measurements, they depend on manual processes. We developed and validated a deep learning algorithm to automatically select and segment abdominal muscles [SM], visceral fat [VAT], and subcutaneous fat [SAT] on CT scans.A total of 352 CT scans were collected from two cancer centers. The detection of the third lumbar vertebrae and three different body tissues (SM, VAT, and SAT) were annotated manually. The 5-fold cross-validation method was used to develop the algorithm and validate its performance on the training cohort. Results were validated on an external independent group of CT scans.The algorithm for automatic L3 slice selection had a mean absolute error of 4 mm for the internal validation dataset and 5.5 mm for the external validation dataset. The median DICE similarity coefficient for body composition was 0.94 for SM, 0.93 for VAT, and 0.86 for SAT in the internal validation dataset whereas it was 0.93 for SM, 0.93 for VAT, and 0.85 for SAT in the external validation dataset. There were high correlation scores with sarcopenia metrics in both internal and external validation datasets.Our deep learning algorithm facilitates routine research use and could be integrated into electronic patient records, enhancing care through better monitoring and the incorporation of targeted supportive measures like exercise and nutrition.","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"81 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139440521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Insights in PET and SPECT: 2023 社论:PET 和 SPECT 透视:2023 年
Frontiers in Nuclear Medicine Pub Date : 2023-12-21 DOI: 10.3389/fnume.2023.1342672
M. Petretta, C. Nappi, Alberto Cuocolo
{"title":"Editorial: Insights in PET and SPECT: 2023","authors":"M. Petretta, C. Nappi, Alberto Cuocolo","doi":"10.3389/fnume.2023.1342672","DOIUrl":"https://doi.org/10.3389/fnume.2023.1342672","url":null,"abstract":"","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"55 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139166476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry 用于 177Lu-PSMA 治疗反应监测和剂量测定的定量成像技术
Frontiers in Nuclear Medicine Pub Date : 2023-12-14 DOI: 10.3389/fnume.2023.1291253
Catherine Meyer, Laszlo Szidonya, Celeste Winters, Anna Mench, Nadine Mallak, Erik Mittra
{"title":"Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry","authors":"Catherine Meyer, Laszlo Szidonya, Celeste Winters, Anna Mench, Nadine Mallak, Erik Mittra","doi":"10.3389/fnume.2023.1291253","DOIUrl":"https://doi.org/10.3389/fnume.2023.1291253","url":null,"abstract":"PSMA-targeted radiopharmaceutical therapy is an established treatment option for metastatic castration-resistant prostate cancer (mCRPC). However, response rates and duration using 177Lu-PSMA-617 vary considerably between patients. Quantitative 177Lu SPECT imaging is one approach that may be leveraged to more closely monitor inter-cycle response, as well as patient-specific absorbed doses. In this work, we describe our experience implementing quantitative imaging throughout the course of 177Lu-PSMA treatment, including serial SPECT imaging to monitor response and for individualized dosimetry. We also describe our imaging protocols and dose calculation workflows for 3D voxelized patient-specific organ and tumor dosimetry, including a review of the current landscape and efforts towards harmonized dosimetry.","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"58 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139179721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study 利用核磁共振成像、[18F]FDG-PET 和[89Zr]Zr-DFO-28H1 FAP-PET 示踪剂评估可重复肺损伤大鼠模型中的炎症和纤维生成:一项多模态成像研究
Frontiers in Nuclear Medicine Pub Date : 2023-12-12 DOI: 10.3389/fnume.2023.1306251
Milou Boswinkel, R. Raavé, A. Veltien, T. Scheenen, N. Fransén Petterson, René in ‘t Zandt, Lars E. Olsson, Karin von Wachenfeldt, Sandra Heskamp, Irma Mahmutovic Persson
{"title":"Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study","authors":"Milou Boswinkel, R. Raavé, A. Veltien, T. Scheenen, N. Fransén Petterson, René in ‘t Zandt, Lars E. Olsson, Karin von Wachenfeldt, Sandra Heskamp, Irma Mahmutovic Persson","doi":"10.3389/fnume.2023.1306251","DOIUrl":"https://doi.org/10.3389/fnume.2023.1306251","url":null,"abstract":"Accurate imaging biomarkers that indicate disease progression at an early stage are highly important to enable timely mitigation of symptoms in progressive lung disease. In this context, reproducible experimental models and readouts are key. Here, we aim to show reproducibility of a lung injury rat model, by inducing disease and assessing disease progression by multi-modal non-invasive imaging techniques at two different research sites. Furthermore, we evaluated the potential of fibroblast activating protein (FAP) as an imaging biomarker in the early stage of lung fibrosis.An initial lung injury rat model was set up at one research site (Lund University, Lund, Sweden) and repeated at a second site (Radboudumc, Nijmegen, The Netherlands). To induce lung injury, Sprague-Dawley rats received intratracheal instillation of bleomycin as one single dose (1,000 iU in 200 µL) or saline as control. Thereafter, longitudinal images were acquired to track inflammation in the lungs, at 1 and 2 weeks after the bleomycin challenge by magnetic resonance imaging (MRI) and [18F]FDG-PET. After the final [18F]FDG-PET scan, rats received an intravenous tracer [89Zr]Zr-DFO-28H1 (anti-FAP antibody) and were imaged at day 15, to track fibrogenesis. Upon termination, bronchoalveolar lavage (BAL) was performed to assess cell and protein concentration. Subsequently, the biodistribution of [89Zr]Zr-DFO-28H1 was measured ex vivo and the spatial distribution in lung tissue was studied by autoradiography. Lung sections were stained, and fibrosis assessed using the modified Ashcroft score.Bleomycin-challenged rats showed body weight loss and increased numbers of immune cells and protein concentrations after BAL compared with control animals. The initiation and progression of the disease were reproduced at both research sites. Lung lesions in bleomycin-exposed rats were visualized by MRI and confirmed by histology. [18F]FDG uptake was higher in the lungs of bleomycin-challenged rats compared with the controls, similar to that observed in the Lund study. [89Zr]Zr-DFO-28H1 tracer uptake in the lung was increased in bleomycin-challenged rats compared with control rats (p = 0.03).Here, we demonstrate a reproducible lung injury model and monitored disease progression using conventional imaging biomarkers MRI and [18F]FDG-PET. Furthermore, we showed the first proof-of-concept of FAP imaging. This reproducible and robust animal model and imaging experimental set-up allows for future research on new therapeutics or biomarkers in lung disease.","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"1 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139182292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases 社论:转移性和代谢性骨病中的定量[18F]NaF PET
Frontiers in Nuclear Medicine Pub Date : 2023-12-11 DOI: 10.3389/fnume.2023.1343913
T. Puri, Amelia E. B. Moore, Abhishek Mahajan, Alan McWilliam, M. Vrist, G. M. Blake
{"title":"Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases","authors":"T. Puri, Amelia E. B. Moore, Abhishek Mahajan, Alan McWilliam, M. Vrist, G. M. Blake","doi":"10.3389/fnume.2023.1343913","DOIUrl":"https://doi.org/10.3389/fnume.2023.1343913","url":null,"abstract":"","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"26 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139183542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field 社论:弗兰克-罗施教授在放射性药物化学领域的遗产
Frontiers in Nuclear Medicine Pub Date : 2023-11-27 DOI: 10.3389/fnume.2023.1336481
C. Poulie, Markus Piel, Bernd Neumaier, Tobias Ross, Matthias Herth
{"title":"Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field","authors":"C. Poulie, Markus Piel, Bernd Neumaier, Tobias Ross, Matthias Herth","doi":"10.3389/fnume.2023.1336481","DOIUrl":"https://doi.org/10.3389/fnume.2023.1336481","url":null,"abstract":"","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"176 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139229711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of dynamic [18F]NaF PET scan duration on kinetic uptake parameters in the knee 动态[18F]NaF PET 扫描持续时间对膝关节动力学摄取参数的影响
Frontiers in Nuclear Medicine Pub Date : 2023-11-24 DOI: 10.3389/fnume.2023.1194961
L. Watkins, Bryan Haddock, Ananya Goyal, Feliks Kogan
{"title":"Effects of dynamic [18F]NaF PET scan duration on kinetic uptake parameters in the knee","authors":"L. Watkins, Bryan Haddock, Ananya Goyal, Feliks Kogan","doi":"10.3389/fnume.2023.1194961","DOIUrl":"https://doi.org/10.3389/fnume.2023.1194961","url":null,"abstract":"Accurately estimating bone perfusion and metabolism using [18F]NaF kinetics from shorter scan times could help address concerns related to patient comfort, motion, and throughput for PET scans. We examined the impact of changing the PET scan duration on the accuracy of [18F]NaF kinetic parameters in the knee.Both knees of twenty participants with and without osteoarthritis were scanned using a hybrid PET-MRI system (53 ± 13 years, BMI 25.9 ± 4.2 kg/m2, 13 female). Seventeen participants were scanned for 54 ± 2 min, and an additional three participants were scanned for 75 min. Patlak Ki and Hawkins kinetic parameters (Ki, K1, extraction fraction) were assessed using 50- or 75-minutes of scan data as well as for scan durations that were retrospectively shortened. The error of the kinetic uptake parameters was calculated in bone regions throughout the knee.The mean error of Patlak Ki, Hawkins Ki, K1, and extraction fraction was less than 10% for scan durations exceeding 30 min and decreased with increasing scan duration.The length of dynamic data acquisition can be reduced to as short as 30 min while retaining accuracy within the limits of reproducibility of Hawkins kinetic uptake parameters.","PeriodicalId":505895,"journal":{"name":"Frontiers in Nuclear Medicine","volume":"148 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139240800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信